Biotechnology and Drug Discovery: From Bench to Bedside

Yoav Avidor, Nicola J. Mabjeesh, Haim Matzkin

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

New biotechnology and drug discovery technologies are facilitating the rapid expansion of the clinical drug chest, empowering clinicians with a better understanding of disease as well as novel modalities for treating patients. Important research tools and themes include genomics, proteomics, ligand-receptor interaction, signal transduction, rational drug design, biochips, and microarrays. Emerging drug classes include monoclonal antibodies, cancer vaccines, gene therapy, antisense strands, enzymes, and proteins. In this article, we review these topics and illustrate their potential impact by presenting an overview of promising drugs in the pipeline. Clinicians who use these novel treatments must become familiar with these trends.

Original languageEnglish
Pages (from-to)1174-1186
Number of pages13
JournalSouthern Medical Journal
Volume96
Issue number12
DOIs
StatePublished - 1 Dec 2003
Externally publishedYes

Keywords

  • Biotechnology
  • Drug classes
  • Drug development

Fingerprint

Dive into the research topics of 'Biotechnology and Drug Discovery: From Bench to Bedside'. Together they form a unique fingerprint.

Cite this